|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heare T, Hensley MA and Dell'Orfano S:
Bone tumors: Osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr.
21:365–372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Levings PP, McGarry SV, Currie TP,
Nickerson DM, McClellan S, Ghivizzani SC, Steindler DA and Gibbs
CP: Expression of an exogenous human Oct-4 promoter identifies
tumor-initiating cells in osteosarcoma. Cancer Res. 69:5648–5655.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fujiwara M, Kashima TG, Kunita A, Kii I,
Komura D, Grigoriadis AE, Kudo A, Aburatani H and Fukayama M:
Stable knockdown of S100A4 suppresses cell migration and metastasis
of osteosarcoma. Tumour Biol. 32:611–622. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hua Y, Jia X, Sun M, Zheng L, Yin L, Zhang
L and Cai Z: Plasma membrane proteomic analysis of human
osteosarcoma and osteoblastic cells: Revealing NDRG1 as a marker
for osteosarcoma. Tumour Biol. 32:1013–1021. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sharili AS, Allen S, Smith K, Hargreaves
J, Price J and McGonnell I: Expression of Snail2 in long bone
osteosarcomas correlates with tumour malignancy. Tumour Biol.
32:515–526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simpson AJ, Caballero OL, Jungbluth A,
Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and
cancer. Nat Rev Cancer. 5:615–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ando K, Uemura K, Kuzuya A, Maesako M,
Asada-Utsugi M, Kubota M, Aoyagi N, Yoshioka K, Okawa K, Inoue H,
et al: N-cadherin regulates p38 MAPK signaling via association with
JNK-associated leucine zipper protein: Implications for
neurodegeneration in Alzheimer disease. J Biol Chem. 286:7619–7628.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kashef K, Lee CM, Ha JH, Reddy EP and
Dhanasekaran DN: JNK-interacting leucine zipper protein is a novel
scaffolding protein in the Galpha13 signaling pathway.
Biochemistry. 44:14090–14096. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee CM, Onésime D, Reddy CD, Dhanasekaran
N and Reddy EP: JLP: A scaffolding protein that tethers JNK/p38MAPK
signaling modules and transcription factors. Proc Natl Acad Sci
USA. 99:14189–14194. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nguyen Q, Lee CM, Le A and Reddy EP: JLP
associates with kinesin light chain 1 through a novel leucine
zipper-like domain. J Biol Chem. 280:30185–30191. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takaesu G, Kang JS, Bae GU, Yi MJ, Lee CM,
Reddy EP and Krauss RS: Activation of p38alpha/beta MAPK in
myogenesis via binding of the scaffold protein JLP to the cell
surface protein Cdo. J Cell Biol. 175:383–388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanojia D, Garg M, Gupta S, Gupta A and
Suri A: Sperm-associated antigen 9, a novel biomarker for early
detection of breast cancer. Cancer Epidemiol Biomarkers Prev.
18:630–639. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Garg M, Kanojia D, Suri S and Suri A:
Small interfering RNA-mediated down-regulation of SPAG9 inhibits
cervical tumor growth. Cancer. 115:5688–5699. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garg M, Kanojia D, Salhan S, Suri S, Gupta
A, Lohiya NK and Suri A: Sperm-associated antigen 9 is a biomarker
for early cervical carcinoma. Cancer. 115:2671–2683. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Garg M, Kanojia D, Suri S, Gupta S, Gupta
A and Suri A: Sperm-associated antigen 9: A novel diagnostic marker
for thyroid cancer. J Clin Endocrinol Metab. 94:4613–4618. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanojia D, Garg M, Gupta S, Gupta A and
Suri A: Sperm-associated antigen 9 is a novel biomarker for
colorectal cancer and is involved in tumor growth and
tumorigenicity. Am J Pathol. 178:1009–1020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schajowicz F, Sissons HA and Sobin LH: The
World Health Organization's histologic classification of bone
tumors. A commentary on the second edition. Cancer. 75:1208–1214.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Dong Q, Miao Y, Fu L, Lin X and
Wang E: Clinical significance and biological roles of SPAG9
overexpression in non-small cell lung cancer. Lung Cancer.
81:266–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garg M, Kanojia D, Khosla A, Dudha N, Sati
S, Chaurasiya D, Jagadish N, Seth A, Kumar R, Gupta S, et al:
Sperm-associated antigen 9 is associated with tumor growth,
migration and invasion in renal cell carcinoma. Cancer Res.
68:8240–8248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie C, Fu L, Liu N and Li Q:
Overexpression of SPAG9 correlates with poor prognosis and tumor
progression in hepatocellular carcinoma. Tumour Biol. 35:7685–7691.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jagadish N, Rana R, Selvi R, Mishra D,
Garg M, Yadav S, Herr JC, Okumura K, Hasegawa A, Koyama K and Suri
A: Characterization of a novel human sperm-associated antigen 9
(SPAG9) having structural homology with c-Jun N-terminal
kinase-interacting protein. Biochem J. 389:73–82. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gantulga D, Tuvshintugs B, Endo Y, Takino
T, Sato H, Murakami S and Yoshioka K: The scaffold protein c-Jun
NH2-terminal kinase-associated leucine zipper protein regulates
cell migration through interaction with the G protein G (alpha 13).
J Biochem. 144:693–700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kashef K, Radhakrishnan R, Lee CM, Reddy
EP and Dhanasekaran DN: Neoplastic transformation induced by the
gep oncogenes involves the scaffold protein JNK-interacting leucine
zipper protein. Neoplasia. 13:358–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miao ZF, Wang ZN, Zhao TT, Xu YY, Wu JH,
Liu XY, Xu H, You Y and Xu HM: Overexpression of SPAG9 in human
gastric cancer is correlated with poor prognosis. Virchows Arch.
467:525–533. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Peng Y, Niu H, Wu B, Zhang Y, Zhang
Y, Bai X and He P: SPAG9 is overexpressed in human prostate cancer
and promotes cancer cell proliferation. Tumour Biol. 35:6949–6954.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mehraein-Ghomi F, Kegel SJ, Church DR,
Schmidt JS, Reuter QR, Saphner EL, Basu HS and Wilding G: Targeting
androgen receptor and JunD interaction for prevention of prostate
cancer progression. Prostate. 74:792–803. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ouafik L, Berenguer-Daize C and Berthois
Y: Adrenomedullin promotes cell cycle transit and up-regulates
cyclin D1 protein level in human glioblastoma cells through the
activation of c-Jun/JNK/AP-1 signal transduction pathway. Cell
Signal. 21:597–608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakachi S, Nakazato T, Ishikawa C, Kimura
R, Mann DA, Senba M, Masuzaki H and Mori N: Human T-cell leukemia
virus type 1 tax transactivates the matrix metalloproteinase 7 gene
via JunD/AP-1 signaling. Biochim Biophys Acta. 1813:731–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Byun HJ, Hong IK, Kim E, Jin YJ, Jeoung
DI, Hahn JH, Kim YM, Park SH and Lee H: A splice variant of CD99
increases motility and MMP-9 expression of human breast cancer
cells through the AKT-, ERK- and JNK-dependent AP-1 activation
signaling pathways. J Biol Chem. 281:34833–34847. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim MS, Park MJ, Kim SJ, Lee CH, Yoo H,
Shin SH, Song ES and Lee SH: Emodin suppresses hyaluronic
acid-induced MMP-9 secretion and invasion of glioma cells. Int J
Oncol. 27:839–846. 2005.PubMed/NCBI
|
|
33
|
Dong QZ, Wang Y, Tang ZP, Fu L, Li QC,
Wang ED and Wang EH: Derlin-1 is overexpressed in non-small cell
lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated
up-regulation of MMP-2 and MMP-9. Am J Pathol. 182:954–964. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Shi Q, Yuan TX, Song QL, Zhang Y,
Wei Q, Zhou L, Luo J, Zuo G, Tang M, et al: Matrix
metalloproteinase 9 (MMP-9) in osteosarcoma: Review and
meta-analysis. Clin Chim Acta. 433:225–231. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim SM, Lee H, Park YS, Lee Y and Seo SW:
ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9. J
Orthop Res. 30:1040–1044. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kook SH, Son YO, Jang YS, Lee KY, Lee SA,
Kim BS, Lee HJ and Lee JC: Inhibition of c-Jun N-terminal kinase
sensitizes tumor cells to flavonoid-induced apoptosis through
down-regulation of JunD. Toxicol Appl Pharmacol. 227:468–476. 2008.
View Article : Google Scholar : PubMed/NCBI
|
